Merck Cost of Goods Sold 2010-2024 | MKKGY
Merck annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Merck cost of goods sold for the quarter ending June 30, 2024 was $2.282B, a 2.16% decline year-over-year.
- Merck cost of goods sold for the twelve months ending June 30, 2024 was $9.431B, a 5.26% increase year-over-year.
- Merck annual cost of goods sold for 2023 was $9.308B, a 3.6% increase from 2022.
- Merck annual cost of goods sold for 2022 was $8.984B, a 3.3% increase from 2021.
- Merck annual cost of goods sold for 2021 was $8.697B, a 11.39% increase from 2020.
Merck Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$9,308 |
| 2022 |
$8,984 |
| 2021 |
$8,697 |
| 2020 |
$7,808 |
| 2019 |
$6,727 |
| 2018 |
$6,356 |
| 2017 |
$6,013 |
| 2016 |
$5,755 |
| 2015 |
$4,523 |
| 2014 |
$4,688 |
| 2013 |
$3,975 |
| 2012 |
$4,061 |
| 2011 |
$3,884 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-06-30 |
$2,282 |
| 2024-03-31 |
$2,292 |
| 2023-12-31 |
$2,504 |
| 2023-09-30 |
$2,353 |
| 2023-06-30 |
$2,332 |
| 2023-03-31 |
$2,118 |
| 2022-12-31 |
$2,347 |
| 2022-09-30 |
$2,162 |
| 2022-06-30 |
$2,244 |
| 2022-03-31 |
$2,230 |
| 2021-12-31 |
$2,246 |
| 2021-09-30 |
$2,192 |
| 2021-06-30 |
$2,184 |
| 2021-03-31 |
$2,075 |
| 2020-12-31 |
$2,134 |
| 2020-09-30 |
$2,076 |
| 2020-06-30 |
$1,773 |
| 2020-03-31 |
$1,825 |
| 2019-12-31 |
$1,876 |
| 2019-09-30 |
$1,644 |
| 2019-06-30 |
$1,635 |
| 2019-03-31 |
$1,572 |
| 2018-12-31 |
$1,596 |
| 2018-09-30 |
$1,563 |
| 2018-06-30 |
$1,575 |
| 2018-03-31 |
$1,623 |
| 2017-12-31 |
$1,641 |
| 2017-09-30 |
$1,527 |
| 2017-06-30 |
$1,464 |
| 2017-03-31 |
$1,381 |
| 2016-12-31 |
$1,432 |
| 2016-09-30 |
$1,396 |
| 2016-06-30 |
$1,485 |
| 2016-03-31 |
$1,442 |
| 2015-12-31 |
$1,258 |
| 2015-09-30 |
$1,045 |
| 2015-06-30 |
$1,123 |
| 2015-03-31 |
$1,098 |
| 2014-12-31 |
$1,283 |
| 2014-09-30 |
$1,258 |
| 2014-06-30 |
$1,137 |
| 2014-03-31 |
$1,009 |
| 2013-12-31 |
$1,057 |
| 2013-09-30 |
$958 |
| 2013-06-30 |
$1,003 |
| 2013-03-31 |
$956 |
| 2012-12-31 |
|
| 2012-09-30 |
$985 |
| 2012-06-30 |
$1,038 |
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
$1,094 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$799 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
